Your session is about to expire
← Back to Search
Intervention: Quality Improvement tools for Iron-Deficiency Anemia
N/A
Waitlist Available
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Northwestern Medical Group primary care physician (internal medicine, family medicine or geriatrics)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 120 days
Awards & highlights
Study Summary
The objective is to determine if a set of clinical supports that includes computer-assisted identification, an EHR registry, facilitated GI referral, and an EHR tool for documentation improves the timely referral and completion of bidirectional endoscopy in men aged 18 years and older and women aged 40 years and older with iron deficiency anemia.
Eligible Conditions
- Iron-Deficiency Anemia
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 120 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~120 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Bidirectional endoscopy completed
Secondary outcome measures
Endoscopy completed or scheduled
GI referral provided or completed
Gastroenterology consultation completed
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention: Quality Improvement toolsExperimental Treatment1 Intervention
Quality improvement tools including: computer-assisted identification of iron deficiency anemia patients with an EHR registry, facilitated GI referral, an EHR tool for documentation, and physician education.
Group II: Control: usual careActive Control1 Intervention
Physicians will be notified at the start of the study that 120 days after the study start they will receive access to the quality improvement tools available to the intervention group.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Clinical supports
2022
N/A
~20
Find a Location
Who is running the clinical trial?
Northwestern UniversityLead Sponsor
1,576 Previous Clinical Trials
911,906 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger